Amplify Therapeutics ApS — Credit Rating and Financial Key Figures

Amplify Therapeutics ApS (CVR number: 43803999) is a company from KØBENHAVN. The company recorded a gross profit of 925.9 kDKK in 2025. The operating profit was -3859.7 kDKK, while net earnings were -3335.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was -24.9 %, which can be considered poor and Return on Equity (ROE) was -71.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -78.7 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Amplify Therapeutics ApS's liquidity measured by quick ratio was 9.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.